Employer-sponsored family health plan costs have risen to an average of $28,303, with workers ultimately bearing the full economic burden through lower wages and deductions from their pay, a commentary argues.
Employees typically see around a quarter of the cost taken directly from their pay packets and assume their employer covers the remainder. But companies generally consider health insurance alongside wages, paid leave, retirement benefits and other employment costs when setting total compensation.
As a result, higher health premiums leave less room for cash wage growth. The average family plan now amounts to 44 per cent of the typical full-time worker’s pre-tax cash wages, according to the analysis.
Roughly 100 million people receive health benefits through large employers that self-insure. In those arrangements, the company pays its workers’ and their families’ healthcare bills, while insurers act mainly as administrators rather than bearing the cost of claims.
The central concern is therefore not simply that insurers are charging employers excessive premiums. It is that the system used to design, price and administer health plans may reward higher healthcare spending.
Benefits consultants face scrutiny over health plan costs
Large self-insured companies commonly rely on major benefits consultants to manage plan design and negotiate contracts. The commentary questions whether those consultants consistently put employers’ and workers’ interests ahead of their own.
One problem is the way value is measured. Hospital deals are often assessed by the size of the discount from a provider’s billed charges, even though those charges are frequently far above the prices hospitals actually receive.
A large discount can therefore produce a higher final payment than a smaller discount applied to a lower charge. As hospital charges rise more quickly than negotiated prices, discounts can appear to improve while the amount paid by the health plan increases.
The same incentives can arise in other parts of the system. Out-of-network claims may be repriced by vendors paid a percentage of the claimed savings, while prescription drug arrangements have traditionally been judged by rebates against manufacturers’ list prices.
In each case, the analysis says, the more meaningful measure is the net price actually paid for care, rather than the size of the discount. Employers are urged to compare prices with an external benchmark, such as Medicare rates, which should be treated as a reference point rather than a target price.
Companies are also advised to examine how benefits consultants are paid. Federal law requires brokers and consultants to disclose direct and indirect compensation, but the commentary argues that employers must also establish whether revenues increase with their health spending or whether recommended vendors provide additional financial benefits.
Calls for finance chiefs to take control
Corporate benefits departments may be reluctant to make changes because unsuccessful decisions can generate complaints, while savings may attract little recognition. The result, the analysis argues, is an incentive to preserve existing arrangements even when they are expensive.
Workers, meanwhile, may not see the full cost clearly. Their contribution is commonly spread across 26 pay packets, making the financial impact less noticeable even as it affects take-home pay and the scope for wage increases.
The proposed response does not require new legislation. Instead, employers are urged to bring finance leaders directly into oversight of the health plan, applying the same scrutiny to contracts, prices and supplier margins as they would to any other major cost.
Consultants should be paid a transparent flat fee rather than commissions linked to premiums or payments from vendors they recommend. Employers should also promise that savings will be reflected in lower employee contributions and higher take-home pay, with the results reported to staff each year.
The commentary argues that hospitals, doctors, pharmaceutical companies and other participants in the healthcare supply chain can benefit when spending rises with little resistance. Workers, who ultimately fund the system through compensation, are left with no corresponding gain.
Employers are therefore urged to treat themselves as stewards of their workers’ healthcare spending and to take seriously their responsibility to run health plans in employees’ best interests.
